Sign in
KRSA Stock Price, Chart, Stats & News
Korsana Biosciences, Inc.
Save
Korsana Biosciences, Inc. (KRSA) does not currently pay a dividend.
145.26M
Market cap
–
Current P/E
–
Forward P/E
KRSA chart
About
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Similar securities
Based on sector and market capitalization
Report issue